New imaging for fibrosis in ulcerative colitis
Part of Digestive system clinical trials.
This study looks at new ways to detect scarring (fibrosis) in the bowel using advanced imaging and tests. It may help doctors better understand and monitor ulcerative colitis. If you are already having a colonoscopy, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have had ulcerative colitis for more than 3 months
- You are scheduled for a colonoscopy as part of your regular care
- You are not pregnant
- You do not have active infections, fluid in the belly (ascites), or any condition that would prevent a colonoscopy (like a severe flare or intolerance to prep)
- You are not planning to change your current ulcerative colitis treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks biomarkers (signals in blood and/or stool) in adults with moderate-to-severe ulcerative colitis. It compares patients starting targeted medicines and looks for marker patterns that may reflect how the disease is behaving.
This study looks at whether a special microscope used during a colonoscopy can help predict how well your ulcerative colitis will respond to a new type of medication called a small molecule. If you're starting this treatment, the results might tell you early if it's likely to work for you.
This study looks at blood and/or tissue “molecular” (cell-level) reasons why treatments don’t fully work in adults with Crohn’s disease or ulcerative colitis. If you are starting a biologic or small-molecule medicine and still have moderate to severe symptoms, you may be able to contribute to research that helps improve future care.
This study compares different special camera techniques during colonoscopy to see which best finds early abnormal (pre-cancer) changes in people with long-term ulcerative colitis. It may help doctors improve how they screen and monitor your colon over time.
This study looks at how bacteria in the gut may affect scarring (fibrosis) in the intestines, especially in people with Crohn's disease. By joining, you may help researchers understand why scarring happens, which could lead to better treatments.
This trial compares how well different combinations of drugs calm inflammation in the gut compared to single drugs. It uses tissue samples taken during a colonoscopy to see which approach works best for people with inflammatory bowel disease.
Hear when a new Ulcerative Colitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.